AbbVie ABBV Global ranking
https://en.wikipedia.org/wiki/AbbVie AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois . It is ranked 6th on the list of largest biomedical companies by revenue . The company's primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis , Crohn's disease , plaque psoriasis , and ulcerative colitis . It also developed Skyrizi ($5 billion in 2022 revenues), an interleukin-23 (IL-23) inhibitor also used to treat autoimmune diseases. Its other major products include Botox ($5 billion in 2022 revenues), Imbruvica to treat cancer ($4.5 billion in 2022 revenues), Rinvoq to treat arthritis ($2.5 billion in 2022 revenues), Venclexta to treat leukemia and...